Over the last 12 months, Thermo Fisher Scientific insiders reported no purchases and 30 sales totaling $156.0M across SEC Form 4 filings. 70% of those filings were made under pre-arranged 10b5-1 trading plans.
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 275 | $627.05 | $172K | -0.2% | plan · 4 tranches |
| Aug 21, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 20,000 | $628.09 | $12.6M | -13.9% | plan · 14 tranches |
| Aug 19, 2026 | Britt Lisa P.Sr. VP and Chief HR Officer · O | ▼ Sale | 11,440 | $613.12 | $7.0M | -43.6% | — |
| Aug 11, 2026 | Shafer Michael DExecutive Vice President · O | ▼ Sale | 25,500 | $600 | $15.3M | -54.8% | plan · 2 tranches |
| Aug 7, 2026 | Holmes Joseph R.VP & Chief Accounting Officer · O | ▼ Sale | 420 | $584.81 | $246K | -12.4% | — |
| Aug 7, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 4,608 | $586.12 | $2.7M | -100% | plan · 12 tranches · indirect |
| Aug 7, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 275 | $586.1 | $161K | -0.2% | plan · 15 tranches |
| Aug 6, 2026 | Britt Lisa P.Sr. VP and Chief HR Officer · O | ▼ Sale | 5,850 | $580 | $3.4M | -28.4% | — |
| Aug 6, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 5,000 | $574.45 | $2.9M | -52% | plan · 9 tranches · indirect |
| Aug 6, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 10,000 | $574.47 | $5.7M | -7.5% | plan · 9 tranches |
| Aug 5, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 5,000 | $575.23 | $2.9M | -34.2% | plan · 11 tranches · indirect |
| Aug 5, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 10,000 | $575.23 | $5.8M | -7.5% | plan · 11 tranches |
| Jul 27, 2026 | Pettiti GianlucaPresident & COO · O | ▼ Sale | 400 | $565 | $226K | -1.6% | plan |
| Apr 27, 2026 | Pettiti GianlucaPresident & COO · O | ▼ Sale | 400 | $462.66 | $185K | -1.6% | plan |
| Mar 11, 2026 | Shafer Michael DExecutive Vice President · O | ▼ Sale | 1,607 | $499.4 | $803K | -7.1% | plan |
| Mar 5, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 4,000 | $514.82 | $2.1M | -3.1% | plan · 13 tranches |
| Mar 4, 2026 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 10,000 | $507.75 | $5.1M | -7.5% | plan · 20 tranches |
| Feb 9, 2026 | Pettiti GianlucaExecutive Vice President · O | ▼ Sale | 400 | $541.2 | $216K | -1.9% | plan |
| Dec 4, 2025 | Lagarde MichelExecutive Vice President & COO · O | ▼ Sale | 22,046 | $563.56 | $12.4M | -20.8% | — |
| Dec 3, 2025 | Lagarde MichelExecutive Vice President & COO · O | ▼ Sale | 62,000 | $582.68 | $36.1M | -48.6% | 3 tranches |
| Dec 2, 2025 | Lowery Frederick M.Executive Vice President · O | ▼ Sale | 13,825 | $589.81 | $8.2M | -49% | plan · 2 tranches |
| Nov 25, 2025 | Shafer Michael DExecutive Vice President · O | ▼ Sale | 10,725 | $600 | $6.4M | -36.4% | plan · 2 tranches |
| Nov 13, 2025 | Lagarde MichelExecutive Vice President & COO · O | ▼ Sale | 4,638 | $594.42 | $2.8M | -16.5% | — |
| Nov 12, 2025 | Britt Lisa P.Sr. VP and Chief HR Officer · O | ▼ Sale | 1,057.577 | $588.26 | $622K | -7.5% | — |
| Nov 10, 2025 | Pettiti GianlucaExecutive Vice President · O | ▼ Sale | 2,975 | $580 | $1.7M | -12.3% | plan · 2 tranches |
| Nov 7, 2025 | Britt Lisa P.Sr. VP and Chief HR Officer · O | ▼ Sale | 10,225 | $571.62 | $5.8M | -42% | 2 tranches |
| Oct 27, 2025 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 24,354 | $571.33 | $13.9M | -17.6% | plan · 16 tranches |
| Oct 24, 2025 | Pettiti GianlucaExecutive Vice President · O | ▼ Sale | 400 | $574.15 | $230K | -1.9% | plan |
| Sep 5, 2025 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 400 | $500.5 | $200K | -0.4% | plan · 3 tranches |
| Aug 29, 2025 | Holmes Joseph R.VP & Chief Accounting Officer · O | ▼ Sale | 385 | $492.63 | $190K | -14.2% | 2 tranches |
| Aug 22, 2025 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 10,000 | $500.96 | $5.0M | -8% | plan · 3 tranches |
| Aug 20, 2025 | CASPER MARC NChairman & CEO · O·D | ▼ Sale | 496 | $500.09 | $248K | -0.4% | plan · 3 tranches |
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Thermo Fisher Scientific filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TMO feed.